Kenvue Inc. (NYSE:KVUE) Shares Sold by Mizuho Securities USA LLC

Mizuho Securities USA LLC cut its stake in shares of Kenvue Inc. (NYSE:KVUE) by 15.9% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 124,188 shares of the company’s stock after selling 23,453 shares during the period. Mizuho Securities USA LLC’s holdings in Kenvue were worth $2,872,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Riverview Trust Co purchased a new stake in shares of Kenvue during the third quarter worth about $30,000. Ashton Thomas Securities LLC acquired a new stake in Kenvue in the 3rd quarter worth about $35,000. Deseret Mutual Benefit Administrators increased its stake in Kenvue by 49.7% during the 3rd quarter. Deseret Mutual Benefit Administrators now owns 1,960 shares of the company’s stock worth $45,000 after buying an additional 651 shares in the last quarter. Studio Investment Management LLC increased its stake in Kenvue by 52.1% during the 2nd quarter. Studio Investment Management LLC now owns 2,468 shares of the company’s stock worth $45,000 after buying an additional 845 shares in the last quarter. Finally, AlphaMark Advisors LLC acquired a new position in shares of Kenvue during the third quarter valued at approximately $77,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

KVUE has been the subject of several research reports. Royal Bank of Canada cut Kenvue from an “outperform” rating to a “sector perform” rating and set a $24.00 price target for the company. in a research report on Tuesday, September 24th. JPMorgan Chase & Co. lifted their target price on shares of Kenvue from $24.00 to $25.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Bank of America increased their target price on shares of Kenvue from $24.00 to $27.00 and gave the company a “buy” rating in a research report on Tuesday, October 22nd. Deutsche Bank Aktiengesellschaft raised their price target on shares of Kenvue from $23.00 to $24.00 and gave the stock a “buy” rating in a research note on Wednesday, August 7th. Finally, UBS Group raised their target price on shares of Kenvue from $20.00 to $22.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 7th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $22.64.

Kenvue Stock Down 0.0 %

Shares of NYSE KVUE opened at $24.08 on Friday. The company has a market capitalization of $46.17 billion, a P/E ratio of 43.78, a P/E/G ratio of 2.15 and a beta of 1.36. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.00 and a quick ratio of 0.69. The company has a 50 day simple moving average of $22.83 and a 200-day simple moving average of $20.82. Kenvue Inc. has a 1 year low of $17.67 and a 1 year high of $24.31.

Kenvue (NYSE:KVUE) last posted its earnings results on Thursday, November 7th. The company reported $0.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.01. Kenvue had a return on equity of 21.43% and a net margin of 6.88%. The company had revenue of $3.90 billion during the quarter, compared to analysts’ expectations of $3.92 billion. During the same quarter last year, the firm earned $0.31 earnings per share. The firm’s quarterly revenue was down .4% compared to the same quarter last year. On average, equities research analysts predict that Kenvue Inc. will post 1.07 earnings per share for the current year.

Kenvue Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, November 27th. Shareholders of record on Wednesday, November 13th will be paid a dividend of $0.205 per share. This represents a $0.82 annualized dividend and a yield of 3.41%. The ex-dividend date is Wednesday, November 13th. Kenvue’s dividend payout ratio (DPR) is presently 149.09%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.